top of page
< Back

How Does Tirzepatide (Mounjaro, Zepbound) Work? Mechanism of Action Explained

FAQ-000104

Direct Answer

Tirzepatide works by simultaneously activating two hormone receptors, GLP-1 and GIP, rather than just one. GLP-1 activation slows digestion and reduces appetite. GIP activation is believed to enhance insulin sensitivity and may improve tolerability. This dual mechanism is associated with greater average weight loss in clinical trials than single-target GLP-1 medications like semaglutide.

Drug Class and Indications

Tirzepatide belongs to the dual GLP-1/GIP receptor agonist class. As Mounjaro, it's indicated for blood sugar control in type 2 diabetes and cardiovascular risk reduction. As Zepbound, it's indicated for chronic weight management and obstructive sleep apnea.

How It Compares

A real, direct head-to-head trial (SURMOUNT-5) found tirzepatide produced 20.2% average weight loss compared to semaglutide's 13.7% over the same period, a real, published comparative result. Tirzepatide has a roughly 5-day half-life, slightly shorter than semaglutide's approximately 7 days, though both support once-weekly dosing.

Bottom Line

Tirzepatide's dual-receptor mechanism represents a real, measurable step up in average trial results compared to single-target GLP-1 medications, part of why it's often considered the more powerful current-generation option, though individual response varies.

References

  • Mounjaro and Zepbound Prescribing Information (FDA)
  • SURMOUNT-5 Trial Data

Related Resources

Related Articles

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. The information on DietApp.com is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

how-does-tirzepatide-mounjaro-zepbound-work

bottom of page